Amplify EP Registry
ConditionAtrial Fibrillation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorHeart Rhythm Clinical and Research Solutions, LLC
About this trial
An observational, prospective, multi-center, non-randomized registry designed to obtain real world clinical experience with the TactiFlex Catheter Ablation system in the treatment of Atrial Fibrillation. Patient assessments will occur at pre procedure and procedure, and 1 year post ablation
Eligibility criteria
Qualifiers
Patients who, in the opinion of the investigator, are candidates for ablation to treat atrial fibrillation.
Plans to undergo an ablation procedure using the TactiFlex Ablation Catheter™, Sensor Enabled™ (TactiFlex SE) manufactured by Abbott.
De Novo or redo AF catheter ablation procedures.
Able and willing to participate in baseline and all follow up evaluations.
Disqualifiers
Enrolled in any other cardiac device clinical trial, investigational drug trial, or any other trial that may confound the results of the ablation procedure.
In the opinion of the investigator, any known contraindication to an ablation procedure or to any device or drug required for use during an ablation procedure as assessed by the investigator.
Trial design
Treatments tested in this trial
- Ablation
Treatment groups
1,100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Heart Rhythm Clinical and Research Solutions, LLC
Lead sponsor
Abbott
Collaborator
Source ClinicalTrials.gov